Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

96.87 -1.35 (-1.37%)
Streaming Delayed Price Updated: 10:57 AM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
2 of the Best Healthcare Stocks You'll Find Today
The advice of Warren Buffett's biggest influencers supports these solid picks. 
Via The Motley Fool
Kansas City Lights the Night with a New Research Institute
SOURCE: Illumina 
Via 3BL Media
Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon
The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded. 
Via Investor's Business Daily
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
SOURCE: Illumina 
Via 3BL Media
Earnings Scheduled For April 27, 2021
Companies Reporting Before The Bell • Camden National (NASDAQ:CAC) is projected to report quarterly earnings at $1.01 per share on revenue of $45.73 million. •... 
Via Benzinga
Illumina Celebrates Earth Day
SOURCE: Illumina 
Via 3BL Media
Illumina To Webcast Upcoming Investor Conference
From Illumina, Inc.
Via Business Wire
Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition
From Illumina, Inc.
Via Business Wire
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
From Illumina, Inc.
Via Business Wire
Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?
Time Magazine is well-known for its annual Time100 Most Influential People issue. The media brand unveiled a new annual list called the TIME100 Most Influential Companies. ... 
Via Benzinga
How Illumina's Q1 Results Delighted Investors
Nearly everything went right for the genomic sequencing pioneer. 
Via The Motley Fool
Illumina Inc (ILMN) Q1 2021 Earnings Call Transcript
ILMN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Illumina: Q1 Earnings Insights
Shares of Illumina (NASDAQ:ILMN) rise in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 15.24% year over year to $1.89,... 
Via Benzinga
Illumina Stock Dips Despite First-Quarter Beat, Strong Earnings Guide
Illumina stock skidded on Tuesday after the medical technology giant reported adjusted income of $1.89 per share on $1.09 billion in sales. 
Via Investor's Business Daily
Tuesday Market Report
Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April. 
Via Talk Markets
Illumina Reports Financial Results for First Quarter of Fiscal Year 2021
From Illumina, Inc.
Via Business Wire
Asia Pacific Single-Cell Analysis Market Worth $1,375 Million by 2025 – Impact of Covid 19 Detailed Analysis
The asia pacific single-cell analysis market is projected to reach $1,375 million by 2025. APAC single-cell analysis market report provides crucial industry insights that will help your business grow. 
Via SBWire
Microfluidics Market Next Big Thing : Biggest Opportunity of 2021 - Qiagen, Abbott Laboratories, Fluidigm Corporation
Edison, NJ -- (SBWIRE) -- 04/27/2021 -- The microfluidics market is segmented into in-vitro diagnostics, pharmaceutical, life science research & manufacturing, and therapeutics. The in-vitro... 
Via SBWire
Illumina Is One of the 2021 TIMES Most Influential Companies
SOURCE: Illumina 
Via 3BL Media
Illumina Named One of Singapore's Best Employers
SOURCE: Illumina 
Via 3BL Media
Molecular Diagnostics Market Worth $31.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global molecular diagnostics market size is projected to reach $31.8 billion by 2026. Oncology testing market report provides crucial industry insights that will help your business grow. 
Via SBWire
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan
The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit. 
Via The Motley Fool
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer Indications
Illumina Inc (NASDAQ: ILMN) and privately-held Kartos Therapeutics have announced a partnership to develop a next-generation sequencing-based TP53 companion... 
Via Benzinga
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
Tesla Hit As The QQQ, SPY And DIA All Fell Today. Here's Why.
U.S. indices traded lower Thursday on reports President Biden will propose a capital gains tax for the wealthy of up to 43.4%, which... 
Via Benzinga
Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic
From Illumina, Inc.
Via Business Wire
Plant Genomics Market Growth Analysis Report, Insights, Outlook, Industry Analysis, Share, Trends, Applications, Types and Forecasts 2028
This report provides detailed historical analysis of global market for Plant Genomics from 2014-2019, and provides extensive market forecasts from 2020-2028 by region/country and subsectors. 
Via SBWire
Tumor Genomics Industry Trends, Revenue, Size, Analysis, Key Players, Growth, Share and Forecast Till 2028
Increasing number of cancer cases, rising government initiatives and projects, new drug developments, and increasing demand for cancer-specific diagnostics are factors driving global tumor genomic... 
Via SBWire
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.